FDA says Covid vaccines that target new variants won’t need large clinical trials to win approval
The FDA said Monday that modified Covid-19 vaccines against new, emerging variants may be authorized without the need for lengthy clinical trials.
(Click On Video to Unmute)
Leave a Reply